Transcription/NN
factor/NN
binding/NN
sites/NNS
downstream/JJ
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
transcription/NN
start/NN
site/NN
are/VBP
important/JJ
for/IN
virus/NN
infectivity/NN
./.

When/WRB
transcriptionally/RB
active/JJ
,/,
the/DT
human/JJ
immunodeficiency/NN
virus/NN
(/(
HIV/NN
)/)
promoter/NN
contains/VBZ
a/DT
nucleosome-free/JJ
region/NN
encompassing/VBG
both/CC
the/DT
promoter/enhancer/NN
region/NN
and/CC
a/DT
large/JJ
region/NN
(/(
255/CD
nucleotides/NNS
[/(
nt/NN
]/)
)/)
downstream/JJ
of/IN
the/DT
transcription/NN
start/NN
site/NN
./.
=====
We/PRP
have/VBP
previously/RB
identified/VBN
new/JJ
binding/VBG
sites/NNS
for/IN
transcription/NN
factors/NNS
downstream/RB
of/IN
the/DT
transcription/NN
start/NN
site/NN
(/(
nt/NN
465/CD
to/TO
720/CD
)/)
:/:
three/CD
AP-1/NN
sites/NNS
(/(
I/CD
,/,
II/CD
,/,
and/CC
III/CD
)/)
,/,
an/DT
AP3-like/JJ
motif/NN
(/(
AP3-L/NN
)/)
,/,
a/DT
downstream/JJ
binding/NN
factor/NN
(/(
DBF/NN
)/)
site/NN
,/,
and/CC
juxtaposed/VBN
Sp1/NN
sites/NNS
./.
=====
Here/RB
,/,
we/PRP
show/VBP
that/IN
the/DT
DBF/NN
site/NN
is/VBZ
an/DT
interferon-responsive/JJ
factor/NN
(/(
IRF/NN
)/)
binding/NN
site/NN
and/CC
that/IN
the/DT
AP3-L/NN
motif/NN
binds/VBZ
the/DT
T-cell-specific/JJ
factor/NN
NF-AT/NN
./.
=====
Mutations/NNS
that/WDT
abolish/VBP
the/DT
binding/NN
of/IN
each/DT
factor/NN
to/TO
its/PRP$
cognate/JJ
site/NN
are/VBP
introduced/VBN
in/IN
an/DT
infectious/JJ
HIV-1/NN
molecular/JJ
clone/NN
to/TO
study/VB
their/PRP$
effect/NN
on/IN
HIV-1/NN
transcription/NN
and/CC
replication/NN
./.
=====
Individual/JJ
mutation/NN
of/IN
the/DT
DBF/NN
or/CC
AP3-L/NN
site/NN
as/RB
well/RB
as/IN
the/DT
double/JJ
mutation/NN
AP-1(III)/AP3-L/NN
did/VBD
not/RB
affect/VB
HIV-1/NN
replication/NN
compared/VBN
to/TO
that/DT
of/IN
the/DT
wild-type/JJ
virus/NN
./.
=====
In/IN
contrast/NN
,/,
proviruses/NNS
carrying/VBG
mutations/NNS
in/IN
the/DT
Sp1/NN
sites/NNS
were/VBD
totally/RB
defective/JJ
in/IN
terms/NNS
of/IN
replication/NN
./.
=====
Virus/NN
production/NN
occurred/VBD
with/IN
slightly/RB
delayed/VBN
kinetics/NNS
for/IN
viruses/NNS
containing/VBG
combined/JJ
mutations/NNS
in/IN
the/DT
AP-1(III)/NN
,/,
AP3-L/NN
,/,
and/CC
DBF/NN
sites/NNS
and/CC
in/IN
the/DT
AP3-L/NN
and/CC
DBF-sites/NNS
,/,
whereas/IN
viruses/NNS
mutated/VBN
in/IN
the/DT
AP-1(I,II,III)/NN
and/CC
AP3-L/NN
sites/NNS
and/CC
in/IN
the/DT
AP-1(I,II,III)/NN
,/,
AP3-L/NN
,/,
and/CC
DBF/NN
sites/NNS
exhibited/VBD
a/DT
severely/RB
defective/JJ
replicative/JJ
phenotype/NN
./.
=====
No/DT
RNA-packaging/JJ
defect/NN
could/MD
be/VB
measured/VBN
for/IN
any/DT
of/IN
the/DT
mutant/JJ
viruses/NNS
as/IN
determined/VBN
by/IN
quantification/NN
of/IN
their/PRP$
HIV/NN
genomic/JJ
RNA/NN
./.
=====
Measurement/NN
of/IN
the/DT
transcriptional/JJ
activity/NN
of/IN
the/DT
HIV-1/NN
promoter/NN
after/IN
transient/JJ
transfection/NN
of/IN
the/DT
HIV-1/NN
provirus/NN
DNA/NN
or/CC
of/IN
long/JJ
terminal/JJ
repeat-luciferase/JJ
constructs/NNS
showed/VBD
a/DT
positive/JJ
correlation/NN
between/IN
the/DT
transcriptional/JJ
and/CC
the/DT
replication/NN
defects/NNS
for/IN
most/JJS
mutants/NNS
./.